These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16984814)

  • 21. An anchored PKA and PDE4 complex regulates subplasmalemmal cAMP dynamics.
    Willoughby D; Wong W; Schaack J; Scott JD; Cooper DM
    EMBO J; 2006 May; 25(10):2051-61. PubMed ID: 16642035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation and induction of cyclic AMP phosphodiesterase (PDE4) in rat pulmonary microvascular endothelial cells.
    Zhu B; Kelly J; Vemavarapu L; Thompson WJ; Strada SJ
    Biochem Pharmacol; 2004 Aug; 68(3):479-91. PubMed ID: 15242814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling.
    Conti M; Richter W; Mehats C; Livera G; Park JY; Jin C
    J Biol Chem; 2003 Feb; 278(8):5493-6. PubMed ID: 12493749
    [No Abstract]   [Full Text] [Related]  

  • 24. Computational investigation of the dynamic control of cAMP signaling by PDE4 isoform types.
    Paes D; Hermans S; van den Hove D; Vanmierlo T; Prickaerts J; Carlier A
    Biophys J; 2022 Jul; 121(14):2693-2711. PubMed ID: 35717559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo selective binding of (R)-[11C]rolipram to phosphodiesterase-4 provides the basis for studying intracellular cAMP signaling in the myocardium and other peripheral tissues.
    Kenk M; Greene M; Thackeray J; deKemp RA; Lortie M; Thorn S; Beanlands RS; DaSilva JN
    Nucl Med Biol; 2007 Jan; 34(1):71-7. PubMed ID: 17210463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A RSK(y) relationship with promiscuous PKA.
    Houslay MD
    Sci STKE; 2006 Aug; 2006(349):pe32. PubMed ID: 16926362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sub-family selective actions in the ability of Erk2 MAP kinase to phosphorylate and regulate the activity of PDE4 cyclic AMP-specific phosphodiesterases.
    Baillie GS; MacKenzie SJ; McPhee I; Houslay MD
    Br J Pharmacol; 2000 Oct; 131(4):811-9. PubMed ID: 11030732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphodiesterase-4 as a potential drug target.
    Zhang KY; Ibrahim PN; Gillette S; Bollag G
    Expert Opin Ther Targets; 2005 Dec; 9(6):1283-305. PubMed ID: 16300476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AKAP signaling complexes: getting to the heart of the matter.
    McConnachie G; Langeberg LK; Scott JD
    Trends Mol Med; 2006 Jul; 12(7):317-23. PubMed ID: 16809066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of GRK and PDE4 activities in the regulation of beta2 adrenergic signaling.
    Xin W; Tran TM; Richter W; Clark RB; Rich TC
    J Gen Physiol; 2008 Apr; 131(4):349-64. PubMed ID: 18347080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of cyclic nucleotide phosphodiesterase isoforms in cAMP compartmentation following beta2-adrenergic stimulation of ICa,L in frog ventricular myocytes.
    Jurevicius J; Skeberdis VA; Fischmeister R
    J Physiol; 2003 Aug; 551(Pt 1):239-52. PubMed ID: 12815180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.
    Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
    Cell Signal; 2001 Mar; 13(3):159-67. PubMed ID: 11282454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of cAMP-specific phosphodiesterases type 4B and 4D (PDE4) splice variants by cAMP signaling in primary cortical neurons.
    D'Sa C; Tolbert LM; Conti M; Duman RS
    J Neurochem; 2002 May; 81(4):745-57. PubMed ID: 12065634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compartmentalized PDE4A5 Signaling Impairs Hippocampal Synaptic Plasticity and Long-Term Memory.
    Havekes R; Park AJ; Tolentino RE; Bruinenberg VM; Tudor JC; Lee Y; Hansen RT; Guercio LA; Linton E; Neves-Zaph SR; Meerlo P; Baillie GS; Houslay MD; Abel T
    J Neurosci; 2016 Aug; 36(34):8936-46. PubMed ID: 27559174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ndel1 alters its conformation by sequestering cAMP-specific phosphodiesterase-4D3 (PDE4D3) in a manner that is dynamically regulated through Protein Kinase A (PKA).
    Collins DM; Murdoch H; Dunlop AJ; Charych E; Baillie GS; Wang Q; Herberg FW; Brandon N; Prinz A; Houslay MD
    Cell Signal; 2008 Dec; 20(12):2356-69. PubMed ID: 18845247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant.
    Erdogan S; Houslay MD
    Biochem J; 1997 Jan; 321 ( Pt 1)(Pt 1):165-75. PubMed ID: 9003416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1).
    MacKenzie SJ; Baillie GS; McPhee I; MacKenzie C; Seamons R; McSorley T; Millen J; Beard MB; van Heeke G; Houslay MD
    Br J Pharmacol; 2002 Jun; 136(3):421-33. PubMed ID: 12023945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cAMP phosphodiesterase-4D7 (PDE4D7) is downregulated in androgen-independent prostate cancer cells and mediates proliferation by compartmentalising cAMP at the plasma membrane of VCaP prostate cancer cells.
    Henderson DJ; Byrne A; Dulla K; Jenster G; Hoffmann R; Baillie GS; Houslay MD
    Br J Cancer; 2014 Mar; 110(5):1278-87. PubMed ID: 24518597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective up-regulation of phosphodiesterase-4 cyclic adenosine 3',5'-monophosphate (cAMP)-specific phosphodiesterase variants by elevated cAMP content in human myometrial cells in culture.
    Méhats C; Tanguy G; Dallot E; Robert B; Rebourcet R; Ferré F; Leroy MJ
    Endocrinology; 1999 Jul; 140(7):3228-37. PubMed ID: 10385419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphodiesterase 4 inhibition synergizes with relaxin signaling to promote decidualization of human endometrial stromal cells.
    Bartsch O; Bartlick B; Ivell R
    J Clin Endocrinol Metab; 2004 Jan; 89(1):324-34. PubMed ID: 14715868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.